Skip to main content
Medexus Pharmaceuticals Inc. logo

Medexus Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · MDP ISIN · CA58410Q2036 LEI · 8945002TBEYY0HLH1M19 TSX Manufacturing
Open in API
Filings indexed 638 across all filing types
Latest filing 2023-10-03 Regulatory Filings
Country CA Canada
Listing TSX MDP

About Medexus Pharmaceuticals Inc.

https://www.medexus.com/en_US

Medexus Pharmaceuticals, Inc. is an innovative specialty pharmaceutical company engaged in the development and commercialization of treatment solutions. The company utilizes a highly scalable North American business model, leveraging a fully integrated infrastructure encompassing commercial operations, supply chain, regulatory affairs, and a dedicated salesforce. Medexus focuses on building a portfolio of specialty and rare disease products across key therapeutic areas, including hematology, hematology-oncology, allergy, dermatology, and rheumatology. Its mission is to deliver quality healthcare products to patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Final short form prospectus – English.pdf
Regulatory Filings
2023-10-03 English
Other material contracts - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Third Amendment to Commercialization and Supply Agreement' and consists of detailed contractual amendments between parties regarding FDA approval timelines, milestone payments, and regulatory obligations. It is a legal contract amendment rather than a financial report, earnings release, or regulatory filing. There is no indication of financial statements, audit information, management changes, or shareholder voting results. The content focuses on contractual terms and conditions related to commercialization and supply, which aligns with M&A or transaction-related documents. However, it is not a merger or acquisition announcement but an amendment to an existing agreement. Given the nature of the document as a contract amendment, it best fits under Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2023-09-29 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing an amendment to an existing license agreement between Medexus Pharmaceuticals and medac GmbH. It discusses the extension of FDA approval timelines and payment terms related to the commercialization of a drug (treosulfan) in the US. There are no financial statements, quarterly or annual results, or detailed financial data presented. The document is not a report but an announcement of a contractual amendment and related business update. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital/Financing Update. It is a regulatory announcement about a business agreement amendment, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-09-29 English
News release - English.pdf
Regulatory Filings
2023-09-21 English
Report of voting results.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Report of Voting Results for Annual Meeting of Shareholders on September 21, 2023' and details the voting outcomes on various shareholder matters including election of directors, appointment of auditors, and amendment of equity incentive compensation plan. It references the annual meeting and provides specific vote percentages and results. The document is short (2846 characters) and focuses solely on the voting results from the AGM, not the full AGM materials or presentations. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-09-21 English
Decision Document (Preliminary).pdf
Regulatory Filings
2023-09-12 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.